Dozens of mosquitoes test positive for West Nile Virus in Lehigh Co
E-cigarette vapour tied to changes in lung cells
No honor roll for DC-area hospitals in annual US News rankings
New Haven police make arrest after dozens of overdoses
Health officials continuing to monitor measles outbreak
Prostate cancer drug extends the lifespan of cancer patients
06 June 2018, 04:31 | Melissa Porter
Image Some men with prostate cancer could live longer thanks to immunotherapy
Black patients experienced higher rates of several hormonal-based toxicities, such as hyperglycemia, hypokalemia, and hot flashes, "suggesting perhaps a greater exposure risk to this medicine", George said. This is for the first time that an immunotherapy has shown to be beneficial for men who suffer with prostate cancer that is responsible for the death of more people in the United Kingdom than the breast cancer.
Nell Barrie, from Cancer Research UK, said: "The next step will be to find out how to tell which men will benefit from taking this drug". As a result, the stimulated immune system recognizes and fights the cancer cells present in the body.
A new study conducted by the Institute of cancer research and the Royal Marsden hospital in London has shown awesome results in patients with prostate cancer.
Yes! Now the prostate cancer patients with hardly weeks or months to live will be able to survive longer if they are subjected to proper immunotherapy treatment. Most prostate cancers are slow growing; however, some grow very quickly. While just 5 percent men who were a part of the trail actually saw their cancer to shrink or disappear after receiving the treatment, many of those had heavily mutated cancers.
Professor de Bono said: "We are planning a new clinical trial, specifically in men with prostate cancer whose tumours have mutations in DNA fix genes, to see if immunotherapy can become a standard part of their treatment". As a result, there is insufficient evidence about possible differences in treatment efficacy and side effects by race.
However, the therapy will not work for most patients.
Only around 20% of cancer patients respond to immunotherapy and researchers do not fully understand why. The latest trial, results of which were presented this weekend at the American Society of Clinical Oncology Meeting in Chicago, examined the genetics of tumors and found that certain groups of prostate cancer patients may benefit from the treatment.
Professor Bono concludes, "This new trial has found that testing for mutations in DNA fix genes could be a valuable marker of who will respond".
Is a 'Fallout: New Vegas' Sequel Coming?
Those assets definitely look like Fallout 4 assets, so a full-on Fallout set around the mysterious Vault 76 could be one solution. The thing that struck us most was the casual announcement of an already complete "Making Of" documentary for Fallout 76 .
New Apple Products That Might Get Announced at Today's Event
Apple Chief Executive Officer Tim Cook speaks at the Apple Worldwide Developer conference in San Jose, Calif., on June 4, 2018. For example , Apple says that an iPhone 6 Plus running iOS 12 will get faster keyboard pop-up and faster app launches.
Women With Early Stage Breast Cancer Can Skip Chemo, Study Says
It was the women in the intermediate stages of 11-25 who oncologists often had differing views when prescribing standards of care. This resulted in a "highly personalised" anti-cancer therapy that yielded "complete tumour regression", the researchers wrote.
Sofia Richie Splits from Scott Disick
According to reports, it was Sofia who called time on their relationship but it's said that " Scott seems fine ". Barts trip, Sofia honored Scott's special day with a sweet Insta pic of the pair embracing in the ocean.